Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. [electronic resource]
Producer: 20000105Description: 1131-6 p. digitalISSN:- 0268-3369
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Body Height
- Bone Marrow Transplantation -- physiology
- Brain Neoplasms -- drug therapy
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Etoposide -- administration & dosage
- Growth -- drug effects
- Human Growth Hormone -- therapeutic use
- Humans
- Infant
- Melphalan -- administration & dosage
- Neuroblastoma -- drug therapy
- Retrospective Studies
- Risk Factors
- Thyroxine -- therapeutic use
- Transplantation, Autologous
- Whole-Body Irradiation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.